← Back to headlines
Eli Lilly's Taltz-Zepbound Combo Shows Breakthrough in Psoriasis-Obesity Trial
Eli Lilly has announced a landmark trial demonstrating a major breakthrough with its Taltz-Zepbound drug combination for treating both psoriasis and obesity.
21 Feb, 17:31 — 21 Feb, 17:31
Sources
Showing 1 of 1 sources
Related Stories
Pathologist Shares Four Simple Rules for Weight Loss
31m ago
British Actress Nikki Sanderson Reveals Abuse Over Pregnancy in Her Forties
35m ago
Son of Blind College Football Player Completes Treatment for Rare Eye Cancer
39m ago
Study Suggests Syphilis-Like Disease Spread in Ancient Vietnam, Challenging Columbus Theory
40m ago